150 related articles for article (PubMed ID: 38691860)
21. Revisiting chordoma with brachyury, a "new age" marker: analysis of a validation study on 51 cases.
Jambhekar NA; Rekhi B; Thorat K; Dikshit R; Agrawal M; Puri A
Arch Pathol Lab Med; 2010 Aug; 134(8):1181-7. PubMed ID: 20670140
[TBL] [Abstract][Full Text] [Related]
22. HOXA7, HOXA9, and HOXA10 are differentially expressed in clival and sacral chordomas.
Jäger D; Barth TFE; Brüderlein S; Scheuerle A; Rinner B; von Witzleben A; Lechel A; Meyer P; Mayer-Steinacker R; Baer AV; Schultheiss M; Wirtz CR; Möller P; Mellert K
Sci Rep; 2017 May; 7(1):2032. PubMed ID: 28515451
[TBL] [Abstract][Full Text] [Related]
23. Chordoma: the entity.
Yakkioui Y; van Overbeeke JJ; Santegoeds R; van Engeland M; Temel Y
Biochim Biophys Acta; 2014 Dec; 1846(2):655-69. PubMed ID: 25193090
[TBL] [Abstract][Full Text] [Related]
24. Factors predicting recurrence after resection of clival chordoma using variable surgical approaches and radiation modalities.
Jahangiri A; Chin AT; Wagner JR; Kunwar S; Ames C; Chou D; Barani I; Parsa AT; McDermott MW; Benet A; El-Sayed IH; Aghi MK
Neurosurgery; 2015 Feb; 76(2):179-85; discussion 185-6. PubMed ID: 25594191
[TBL] [Abstract][Full Text] [Related]
25. A Diagnostic Pitfall: Atypical Teratoid Rhabdoid Tumor Versus Dedifferentiated/Poorly Differentiated Chordoma: Analysis of a Mono-institutional Series.
Buccoliero AM; Caporalini C; Scagnet M; Baroni G; Moscardi S; Mussa F; Giordano F; Sardi I; Genitori L
Appl Immunohistochem Mol Morphol; 2019 Feb; 27(2):147-154. PubMed ID: 28777153
[TBL] [Abstract][Full Text] [Related]
26. Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas.
Vujovic S; Henderson S; Presneau N; Odell E; Jacques TS; Tirabosco R; Boshoff C; Flanagan AM
J Pathol; 2006 Jun; 209(2):157-65. PubMed ID: 16538613
[TBL] [Abstract][Full Text] [Related]
27. Transcriptome comparison identifies potential biomarkers of spine and skull base chordomas.
Bell AH; DeMonte F; Raza SM; Rhines LD; Tatsui CE; Prieto VG; Fuller GN; Bell D
Virchows Arch; 2018 Mar; 472(3):489-497. PubMed ID: 28844110
[TBL] [Abstract][Full Text] [Related]
28. The clinical outcomes for chordomas in the cranial base and spine: A single center experience.
Zhou Y; Hu B; Wu Z; Cheng H; Dai M; Zhang B
Medicine (Baltimore); 2019 Jun; 98(23):e15980. PubMed ID: 31169734
[TBL] [Abstract][Full Text] [Related]
29. Management and outcome of chordomas in the pediatric population: The Hospital for Sick Children experience and review of the literature.
Tsitouras V; Wang S; Dirks P; Drake J; Bouffet E; Hawkins C; Laughlin S; Rutka JT
J Clin Neurosci; 2016 Dec; 34():169-176. PubMed ID: 27590862
[TBL] [Abstract][Full Text] [Related]
30. Characterization of T gene sequence variants and germline duplications in familial and sporadic chordoma.
Kelley MJ; Shi J; Ballew B; Hyland PL; Li WQ; Rotunno M; Alcorta DA; Liebsch NJ; Mitchell J; Bass S; Roberson D; Boland J; Cullen M; He J; Burdette L; Yeager M; Chanock SJ; Parry DM; Goldstein AM; Yang XR
Hum Genet; 2014 Oct; 133(10):1289-97. PubMed ID: 24990759
[TBL] [Abstract][Full Text] [Related]
31. Chordoma: Immunohistochemical Analysis of Brachury.
Sun HI; Guduk M; Gucyetmez B; Yapicier O; Pamir MN
Turk Neurosurg; 2018; 28(2):174-178. PubMed ID: 28094431
[TBL] [Abstract][Full Text] [Related]
32. Surgical Resection and Adjuvant Radiation Therapy in the Treatment of Skull Base Chordomas.
Sanusi O; Arnaout O; Rahme RJ; Horbinski C; Chandler JP
World Neurosurg; 2018 Jul; 115():e13-e21. PubMed ID: 29545225
[TBL] [Abstract][Full Text] [Related]
33. Non-rhabdoid pediatric SMARCB1-deficient tumors: overlap between chordomas and malignant rhabdoid tumors?
Renard C; Pissaloux D; Decouvelaere AV; Bourdeaut F; Ranchère D
Cancer Genet; 2014 Sep; 207(9):384-9. PubMed ID: 25053104
[TBL] [Abstract][Full Text] [Related]
34. Establishment of clival chordoma cell line MUG-CC1 and lymphoblastoid cells as a model for potential new treatment strategies.
Gellner V; Tomazic PV; Lohberger B; Meditz K; Heitzer E; Mokry M; Koele W; Leithner A; Liegl-Atzwanger B; Rinner B
Sci Rep; 2016 Apr; 6():24195. PubMed ID: 27072875
[TBL] [Abstract][Full Text] [Related]
35. Chordomas: A Review.
George B; Bresson D; Herman P; Froelich S
Neurosurg Clin N Am; 2015 Jul; 26(3):437-52. PubMed ID: 26141362
[TBL] [Abstract][Full Text] [Related]
36. T (brachyury) gene duplication confers major susceptibility to familial chordoma.
Yang XR; Ng D; Alcorta DA; Liebsch NJ; Sheridan E; Li S; Goldstein AM; Parry DM; Kelley MJ
Nat Genet; 2009 Nov; 41(11):1176-8. PubMed ID: 19801981
[TBL] [Abstract][Full Text] [Related]
37. Skull base chordomas: clinical outcome in a consecutive series of 45 patients with long-term follow-up and evaluation of clinical and biological prognostic factors.
Boari N; Gagliardi F; Cavalli A; Gemma M; Ferrari L; Riva P; Mortini P
J Neurosurg; 2016 Aug; 125(2):450-60. PubMed ID: 26745472
[TBL] [Abstract][Full Text] [Related]
38. The brachyury Gly177Asp SNP is not associated with a risk of skull base chordoma in the Chinese population.
Wu Z; Wang K; Wang L; Feng J; Hao S; Tian K; Zhang L; Jia G; Wan H; Zhang J
Int J Mol Sci; 2013 Oct; 14(11):21258-65. PubMed ID: 24232574
[TBL] [Abstract][Full Text] [Related]
39. New Prospects for Molecular Targets for Chordomas.
Ozair MZ; Shah PP; Mathios D; Lim M; Moss NS
Neurosurg Clin N Am; 2020 Apr; 31(2):289-300. PubMed ID: 32147018
[TBL] [Abstract][Full Text] [Related]
40. Chordomas of the Skull Base, Mobile Spine, and Sacrum: An Epidemiologic Investigation of Presentation, Treatment, and Survival.
Zuckerman SL; Bilsky MH; Laufer I
World Neurosurg; 2018 May; 113():e618-e627. PubMed ID: 29486315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
